TY - JOUR
T1 - Third transmembrane domain of the Adrenocorticotropic Receptor Is Critical for Ligand Selectivity and Potency
AU - Yang, Yingkui
AU - Mishra, Vinod
AU - Crasto, Chiquito J.
AU - Chen, Min
AU - Dimmitt, Reed
AU - Harmon, Carroll M.
N1 - Publisher Copyright:
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2015/3/20
Y1 - 2015/3/20
N2 - The ACTH receptor, known as the melanocortin-2 receptor (MC2R), plays an important role in regulating and maintaining adrenocortical function. MC2R is a subtype of the melanocortin receptor (MCR) family and has unique characteristics among MCRs. Endogenous ACTH is the only endogenous agonist for MC2R, whereas the melanocortin peptides α-, β-, and γ-melanocyte-stimulating hormone and ACTH are full agonists for all other MCRs. In this study, we examined the molecular basis of MC2R responsible for ligand selectivity using ACTH analogs and MC2R mutagenesis. Our results indicate that substitution of Phe7 with D-Phe or D-naphthylalanine (D-Nal(2′)) in ACTH(1-24) caused a significant decrease in ligand binding affinity and potency. Substitution of Phe7 with D-Nal(2′) in ACTH(1-24) did not switch the ligand from agonist to antagonist at MC2R, which was observed in MC3R and MC4R. Substitution of Phe7 with D-Phe7 in ACTH(1-17) resulted in the loss of ligand binding and activity. Molecular analysis of MC2R indicated that only mutation of the third transmembrane domain of MC2R resulted in a decrease in D-Phe ACTH binding affinity and potency. Our results suggest that Phe7 in ACTH plays an important role in ligand selectivity and that the third transmembrane domain of MC2R is crucial for ACTH selectivity and potency.
AB - The ACTH receptor, known as the melanocortin-2 receptor (MC2R), plays an important role in regulating and maintaining adrenocortical function. MC2R is a subtype of the melanocortin receptor (MCR) family and has unique characteristics among MCRs. Endogenous ACTH is the only endogenous agonist for MC2R, whereas the melanocortin peptides α-, β-, and γ-melanocyte-stimulating hormone and ACTH are full agonists for all other MCRs. In this study, we examined the molecular basis of MC2R responsible for ligand selectivity using ACTH analogs and MC2R mutagenesis. Our results indicate that substitution of Phe7 with D-Phe or D-naphthylalanine (D-Nal(2′)) in ACTH(1-24) caused a significant decrease in ligand binding affinity and potency. Substitution of Phe7 with D-Nal(2′) in ACTH(1-24) did not switch the ligand from agonist to antagonist at MC2R, which was observed in MC3R and MC4R. Substitution of Phe7 with D-Phe7 in ACTH(1-17) resulted in the loss of ligand binding and activity. Molecular analysis of MC2R indicated that only mutation of the third transmembrane domain of MC2R resulted in a decrease in D-Phe ACTH binding affinity and potency. Our results suggest that Phe7 in ACTH plays an important role in ligand selectivity and that the third transmembrane domain of MC2R is crucial for ACTH selectivity and potency.
UR - http://www.scopus.com/inward/record.url?scp=84925337336&partnerID=8YFLogxK
U2 - 10.1074/jbc.M114.596122
DO - 10.1074/jbc.M114.596122
M3 - Article
C2 - 25605722
AN - SCOPUS:84925337336
SN - 0021-9258
VL - 290
SP - 7685
EP - 7692
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 12
ER -